Ionis Pharmaceuticals, University of Texas MD Anderson Cancer Center deal

Ionis and MD Anderson Cancer Center partnered to discover and develop cancer therapeutics. Both partners will be responsible for validating targets based on human genomic data. Ionis will lead drug di...